Navigate Up
Behavioral Science

​HANC facilitates the trans-NIH institute, cross-network Behavioral Science Working Group (BSWG). The BSWG’s overarching goal is to ensure that the DAIDS clinical trials networks benefit from state-of-the-science methods and procedures that optimize adherence to product and risk reduction counseling and minimize the risk of confounding user and product failures. Further, the BSWG endeavors to maximize fiscal and scientific resources, reduce redundancies, improve cross-network communication and collaboration, and ensure that the best quality behavioral science is integrated into clinical trials.

​“Prevention Adherence in the DAIDS HIV Clinical Trial Networks” Meeting

The 2008 meeting objectives were to: facilitate cross-network communication and collaboration, review the relevant adherence literature, explore lessons for improving adherence measurement and counseling, identify a prevention adherence research agenda for network trials. The BSWG was formed as a result of this meeting.

More information

​BSWG F2F Meeting

The 2010 BSWG Face-to-Face meeting was held in Miami Beach, Florida. The meeting addressed efficacy dilution in the HIV/AIDS clinical trials. Attendees included investigators from the ACTG, CDC, ATN, HPTN, HVTN, IMPAACT, INSIGHT, MHRP, MTN, FHI, SCHARP, SDAC and NIH staff. The meeting participants discussed issues related to:

  • Efficacy dilution
  • Recruitment and enrollment
  • Risk assessment and reduction
  • Real-time adherence measures
  • Novel technologies

The full meeting report and executive summary will be available soon.

NIMH logo

NIMH

The BSWG is supported by The National Institute of Mental Health (NIMH).

More information

Digg Delicious Facebook Newsvine Reddit StumbleUpon Twitter Email Link

share:

© HIV/AIDS Network Coordination